Company Details
Renova Therapeutics
701 Palomar Airport Road, Suite 300, Carlsbad, CA, 92011, United States
Overview
Renova Therapeutics is a San Diego-based biopharmaceutical company developing therapies for congestive heart failure and other diseases. The company announced a $7.52M Series C funding round. The financing primarily came from high-net-worth individuals. As part of the funding, Daniel M. Bradbury joined Renova's board. Bradbury is a member of life sciences consulting and investment firm BioBrit LLC and previously served as President and CEO of Amylin Pharmaceuticals.
- Total raised
- $8M
- Funding rounds
- 1
- Latest round
- Series C
- Latest activity
- Nov 2014
Industries
- Biopharma
- Biotechnology
- Health Care
- Therapeutics
Recent funding
Series C
Nov 2014
$8M
Team
No current team members are available.